Chad J. Kolean - 14 Feb 2025 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Chief Financial Officer
Signature
/s/ Christina Blakley, attorney-in-fact for Chad J. Kolean
Issuer symbol
CLRB
Transactions as of
14 Feb 2025
Transactions value $
$0
Form type
4
Filing time
18 Feb 2025, 16:04:18 UTC
Previous filing
18 Jun 2024
Next filing
03 Jul 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +290K $0.00 290K 14 Feb 2025 Common Stock 290K $0.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest over a period of three years from February 14, 2025, with 1/3 vesting on the first anniversary of February 14, 2026 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of February 14, 2026.